Current Employment Position(s)

Partner

Lawyer Overview

Anthony Insogna has almost 20 years of experience representing clients in intellectual property matters including patent litigation, patent prosecution, strategic counseling, technology transactions, and due diligence. He has prosecuted and enforced worldwide patent portfolios for some of the most successful therapeutics developed by pharmaceutical, biotechnology, and medical device companies. Anthony has significant experience with the patent and FDA laws under the Hatch-Waxman Act, and he regularly handles IP issues attendant to mergers, acquisitions, partnerships, strategic collaborations, licensing, and financing for life sciences companies.

Representative clients include Celgene, MedImmune, Sepracor, Isis Pharmaceuticals, Amgen, AstraZeneca, Amyris Biotechnologies, BioSphere Medical, PTC Therapeutics, Mitsui Ventures, Ambit Biosciences, as well as investment banks and other private equity firms. Anthony's experience includes patent portfolio development and management, patent infringement actions, oppositions, patent interferences, invalidation proceedings, and strategic transactions for products including Clofar®, Clarinex®, Embospheres®, HepaSpheres®, Tyzeka®, Ethyol®, Synagis®, Focalin®, Focalin XR®, Ritalin LA®, Relafen®, Pristiq®, Allegra®, Thalomid® and others, as well as many product candidates currently in clinical trials.

Anthony is Partner-in-Charge of the San Diego Office.

Areas of Practice

• Intellectual Property
• Patent Litigation
• Patent Prosecution
• Life Sciences
• Biotechnology
• Pharmaceuticals

Representative Cases

• BioSphere Medical, Inc. v. Artes Medical USA, Inc. (D. Del.); Artes Medical USA, Inc. v. BioSphere Medical, Inc. (S.D. Cal.)
• Celgene Corporation et al. v. Abrika Pharmaceuticals, Inc. et al., (D. N.J. 2006)
• Celgene Corporation, Novartis Pharmaceuticals Corporation, and Novartis Pharma AG v. Teva Pharmaceuticals USA, Inc., (several actions)
• Estée Lauder, Inc. v. L'Oreal, S.A.
• In re '639 Patent Litigation
• International Nutrition Co. v. Horphag Research Ltd.
• Acquisition of Ranbaxy Laboratories
• Establishing Patent Portfolio for Embosphere®
• Establishing Patent Portfolio for Various Approved Products
• Establishing Patent Portfolio of Small Molecule
• Establishing Patent Portfolio of Small Molecule Kinase Inhibitors
• Patent Due Diligences
• Patent Portfolio
• Patent Prosecution
• Patent Prosecution
• Patent Prosecution
• Patent Prosecution
• Patent Prosecution
• Patent Prosecution
• Patent Prosecution & Strategy
• Patent Prosecution for Certain Antisense Clinical Candidates
• Patent Prosecution of Ethyol® (Amifostine)
• Patent Prosecution of Peptide and Small Molecule Programs
• Patent Prosecution of Small Molecule Programs
• Patent Prosecution of Synagis® and Numax™
• Patent Prosecution of Thalomid® (Thalidomide), IMiDs™, and SelCIDS™

West Practice Categories

Copyrights, Intellectual Property Law, International Intellectual Property, Patent Litigation, Patents, Technology Licensing, Trade Dress, Trade Secrets, Trademarks

Bar Admissions

• California
• District of Columbia
• New York, First Department

Education

• Fordham University

Published Works

• Biofuels: A (Carbon) Balanced Act, The Daily Transcript, Vol. 123, No. 223, 2008
• CIRM Funding Worth the Cost of Rules, Restrictions?, The Daily Transcript, Vol. 123, No. 208, 2008
• Handle with care, IP rights in developing countries, Patent World Issue #191, 2007
• Five Questions on the New Stem Cell Initiative, California Lawyer, 2005
• States Fund Stem Cell Research, Biotechnology, The National Law Journal, 2005
• A Reinvestigation of the Reactions Occurring upon Photoexcitation of Cyclophexenome in the Presence of Triethylamine, The Journal of Organic Chemistry, Vol. 56, pages 1879-1882., 1991

Address

12265 El Camino Real Suite 200
San Diego, CA 92130-4096

Phones

1.858.314.1130 (Business Phone)

Faxes

1.858.314.1150 (Business Fax)

Emails

Contact Us (Business Email)

Websites

http://www.jonesday.com